liu.seSök publikationer i DiVA
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: Towards personalized medicine
Department of Human Anatomy and Cell Science, University of Manitoba, Winnipeg, Canada; Manitoba Institute of Child's Health (MICH), University of Manitoba, Winnipeg, Canada.
Institute of Human Genetics, University of Aarhus, Denmark.
Department of Sports Medicine, Institute of Sport Sciences, University Giessen, Germany.
Department of Sports Medicine, Institute of Sport Sciences, University Giessen, Germany.
Visa övriga samt affilieringar
2006 (Engelska)Ingår i: Drug resistance updates, ISSN 1368-7646, E-ISSN 1532-2084, Vol. 9, nr 4-5, s. 198-210Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

The rapid development of new diagnostic procedures, the mapping of the human genome, progress in mapping genetic polymorphisms, and recent advances in nucleic acid- and protein chip technologies are driving the development of personalized therapies. This breakthrough in medicine is expected to be achieved largely due to the implementation of "lab-on-the-chip" technology capable of performing hundreds, even thousands of biochemical, cellular and genetic tests on a single sample of blood or other body fluid. Focusing on a few disease-specific examples, this review discusses selected technologies and their combinations likely to be incorporated in the "lab-on-the-chip" and to provide rapid and versatile information about specific diseases entities. Focusing on breast cancer and after an overview of single-nucleofide polymorphism (SNP)-screening methodologies, we discuss the diagnostic and prognostic importance of SNPs. Next, using Duchenne muscular dystrophy (DMD) as an example, we provide a brief overview of powerful and innovative integration of traditional immuno-histochemistry techniques with advanced biophysical methods such as NMR-spectroscopy or Fourier-transformed infrared (FT-IR) spectroscopy. A brief overview of the challenges and opportunities provided by protein and aptamer microarrays follows. We conclude by highlighting novel and promising biochemical markers for the development of personalized treatment of cancer and other diseases: serum cytochrome c, cytokeratin-18 and -19 and their proteolytic fragments for the detection and quantitation of malignant tumor mass, tumor cell turn-over, inflammatory processes during hepatitis and Epstein-Barr virus (EBV)-induced hemophagocytic lymphohistiocytosis and apoptotic/necrotic cancer cell death. (c) 2006 Elsevier Ltd. All rights reserved.

Ort, förlag, år, upplaga, sidor
Elsevier, 2006. Vol. 9, nr 4-5, s. 198-210
Nyckelord [en]
breast-cancer, cyfra 21-1, cytochrome c, cytochrome-c, cytokeratin fragments, Duchenne muscular dystrophy, duchenne muscular-dystrophy, fragment analysis system, in-vivo, lab-on-the-chip, magnetic-resonance, mdx mouse dystrophy, non-hodgkins-lymphoma, personalized cancer therapy, programmed cell-death, single-nucleotide polymorphisms, tps
Nationell ämneskategori
Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci) Biokemi och molekylärbiologi Genetik
Identifikatorer
URN: urn:nbn:se:liu:diva-86983DOI: 10.1016/j.drup.2006.08.001ISI: 000242714300002OAI: oai:DiVA.org:liu-86983DiVA, id: diva2:584095
Tillgänglig från: 2013-01-08 Skapad: 2013-01-08 Senast uppdaterad: 2017-12-06

Open Access i DiVA

fulltext(178 kB)808 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 178 kBChecksumma SHA-512
836a883a24bfe7c211d1e135f8ebabb36de7026f5f02e88e4892dfdc81f52477c1f9b9c1b70e167a8bfc37bdf014de67d0245f269b2ec226b888f7149b90cd96
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltext

Personposter BETA

Los, Marek Jan

Sök vidare i DiVA

Av författaren/redaktören
Los, Marek Jan
I samma tidskrift
Drug resistance updates
Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)Biokemi och molekylärbiologiGenetik

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 808 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
urn-nbn

Altmetricpoäng

doi
urn-nbn
Totalt: 1027 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf